Abstract
Objective
Alendronate (ALN) are pyrophosphates which prevent bone resorption and aid in periodontal regeneration. The present review aimed to evaluate the success of surgical periodontal therapy in the management of intrabony/ furcation defects with and without topical application of ALN.
Method
Using combinations of different search terms, the authors searched the standard electronic databases for randomised controlled trials. Version 2 of the Cochrane risk of bias tool for randomised trials was used for quality appraisal. The random-effects model was used for the statistical analysis of estimated effect sizes. The overall quality of evidence was assessed using GRADEpro GDT software.
Results
Nine studies satisfying all inclusion criteria were selected for qualitative analysis, and six studies with homogeneous data were selected for quantitative analysis. The overall risk of bias had “low” concerns in one study, “some” concerns in four studies, and “high” concerns in four studies. The pooled analysis showed that the experimental group showed a significant reduction in periodontal probing depth(PPD) and defect depth(DD) with a standard mean difference(SDM) of 1.06 mm (95% CI, 0.77–1.34; P < 0.00001; I2 = 0%) and 1.10 mm (95% CI, 0.65–1.54; P < 0.00001; I2 = 56%) respectively, significant improvement in the clinical attachment level (CAL) with SDM of 1.03 mm (95% CI, 0.42-1.64; P = 0.0009; I2 = 76%).
Conclusions
The topical application of ALN has been shown to enhance the effectiveness of surgical periodontal therapy by reducing the PPD and DD and increasing the CAL; however, the certainty of evidence remains very low to low.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
Data availability
The data supporting this article can be made available by the corresponding author upon request.
References
Kwon TH, Lamster IB, Levin L. Current Concepts in the Management of Periodontitis. Int Dent J. 2021;71:462–76. https://doi.org/10.1111/IDJ.12630.
Jepsen K, Sculean A, Jepsen S. Complications and treatment errors related to regenerative periodontal surgery. Periodontol 2000. 2023;92:120–34. https://doi.org/10.1111/PRD.12504.
Reynolds MA, Kao RT, Camargo PM, Caton JG, Clem DS, Fiorellini JP, et al. Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop. J Periodontol. 2015;86. https://doi.org/10.1902/JOP.2015.140378.
Lin Z, Rios HF, Cochran DL Emerging regenerative approaches for periodontal reconstruction: a systematic review from the AAP Regeneration Workshop. J Periodontol. 2015;86. https://doi.org/10.1902/JOP.2015.130689.
Liang Y, Luan X, Liu X. Recent advances in periodontal regeneration: A biomaterial perspective. Bioact Mater. 2020;5:297–308. https://doi.org/10.1016/J.BIOACTMAT.2020.02.012.
Kwoen MJ, Park JH, Kim KS, Lee JR, Kim JW, Lee H, et al. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: A national cohort-based study. J Periodontol. 2023;94:98–107. https://doi.org/10.1002/JPER.21-0611.
Alwithanani N. Role of bisphosphonates in periodontal diseases: systematic review. J Pharm Bioallied Sci. 2023;15:S46–S53. https://doi.org/10.4103/JPBS.JPBS_504_22.
Veena H, Prasad D. Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects. J Indian Soc Periodontol. 2010;14:40 https://doi.org/10.4103/0972-124X.65438.
Gupta J, Gill AS, Sikri P. Evaluation of the relative efficacy of an alloplast used alone and in conjunction with an osteoclast inhibitor in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J Dent Res. 2011;22:225–31. https://doi.org/10.4103/0970-9290.84292.
Carvalho Dutra B, Oliveira AMSD, Oliveira PAD, Miranda Cota LO, Silveira JO, Costa FO. Effects of topical application of 1% sodium alendronate gel in the surgical treatment of periodontal intrabony defects: A 6-month randomized controlled clinical trial. J Periodontol. 2019;90:1079–87. https://doi.org/10.1002/JPER.19-0160.
Kanoriya D, Pradeep AR, Singhal S, Garg V, Guruprasad CN. Synergistic approach using platelet-rich fibrin and 1% alendronate for intrabony defect treatment in chronic periodontitis: a randomized clinical trial. J Periodontol. 2016;87:1427–35. https://doi.org/10.1902/JOP.2016.150698.
Naineni R, Ravi V, Subbaraya DK, Prasanna JS, Panthula VR, Koduganti RR. Effect of alendronate with β - TCP bone substitute in surgical therapy of periodontal intra-osseous defects: a randomized controlled clinical trial. J Clin Diagn Res. 2016;10:ZC113–ZC117. https://doi.org/10.7860/JCDR/2016/20965.8365.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. https://doi.org/10.1136/BMJ.N71.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343. https://doi.org/10.1136/BMJ.D5928.
Zhang Y, Akl EA, Schünemann HJ. Using systematic reviews in guideline development: the GRADE approach. Res Synth Methods. 2018;10:312–29. https://doi.org/10.1002/JRSM.1313.
McMaster University. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. Evidence Prime, Inc. Published online (2015).
Wanikar I, Rathod S, Kolte AP. Clinico-radiographic evaluation of 1% alendronate gel as an adjunct and smart blood derivative platelet rich fibrin in grade II furcation defects. J Periodontol. 2019;90:52–60. https://doi.org/10.1002/JPER.18-0146.
Kanoriya D, Pradeep AR, Garg V, Singhal S. Mandibular Degree II furcation defects treatment with platelet-rich fibrin and 1% Alendronate gel combination: a randomized controlled clinical trial. J Periodontol. 2017;88:250–8. https://doi.org/10.1902/JOP.2016.160269.
Selvalakshmi Saravanan G, Kumar NT, Kumar RSRVRJM. Effect of bone graft and platelet rich fibrin with and without alendronate in the management of intrabony periodontal defect – a randomized clinical study. J Chem Health Risks. 2024;14:287–96. https://doi.org/10.52783/JCHR.V14.I5.6109.
Mat AL-khaiyat SS, HR, Abdulbaqi MT. Mandibular Degree II Furcation Defect Treatment With 1% Alendronate Gel Alone or In Combination with Platelet-Rich Fibrin. J Pharmaceut Sci Res. 2019;11:1856–60. https://www.researchgate.net/profile/Saif-Saliem/publication/339091576_Mandibular_Degree_II_Furcation_Defect_Treatment_With_1Alendronate_Gel_Alone_or_In_Combination_with_Platelet-_Rich_Fibrin/links/5e3d5188299bf1cdb9151708/Mandibular-Degree-II-Furcation-Defect-Treatment-With-1Alendronate-Gel-Alone-or-In-Combination-with-Platelet-Rich-Fibrin.pdf Accessed November 16, 2024.
Kitasato S, Tanaka T, Chazono M, Komaki H, Kakuta A, Inagaki N, et al. Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2. J Biomed Mater Res A. 2020;108:528–36. https://doi.org/10.1002/JBM.A.36833.
Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:834–40. https://doi.org/10.1016/J.JCLINEPI.2010.02.005.
Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol. 2011;64:1283–93. https://doi.org/10.1016/J.JCLINEPI.2011.01.012.
Author information
Authors and Affiliations
Contributions
Pravin Kumar formulated the concept and design. Arun Kumar Patnana and A Rizwan Ali conducted literature search, data extraction from the included articles. Pravin Kumar, Arun Kumar Patnana, A Rizwan Ali and Karishma Pathak were involved in the analysis and interpretation of the data. Pravin Kumar, Arun Kumar Patnana, Ankita Chugh and Kirti Chaudhry drafted the manuscript. Pravin Kumar critically revised the manuscript and approved the final version to be published.
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ali, A.R., Patnana, A.K., Kumar, P. et al. Surgical periodontal therapy for the management of intrabony/furcation defects with and without topically delivered Alendronate - a systematic review and meta-analysis. Evid Based Dent 26, 156–157 (2025). https://doi.org/10.1038/s41432-025-01165-0
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41432-025-01165-0


